Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
TELOMERES AND CELLULAR AGING: BIOLOGICAL MECHANISMS AND
CLINICAL IMPLICATIONS
Umarova Zulfizar
Department of ,,Medical biology and histology”,
Andijan State Medical institute
Abstract:
Telomeres, the repetitive nucleotide sequences at the ends of linear chromosomes,
serve as protective caps that preserve genomic stability. With each round of cell division,
telomeres progressively shorten, eventually leading to cellular senescence or apoptosis. This
process of telomere attrition is now recognized as a key contributor to organismal aging and
age-related diseases. In this article, we explore the molecular biology of telomeres, the
function of telomerase in maintaining telomere length, and the implications of telomere
dynamics in human health. Special emphasis is placed on the role of telomere shortening in
cancer, cardiovascular disorders, and age-associated degeneration, as well as on emerging
therapeutic strategies aimed at telomere preservation.
Keywords:
Telomeres, cellular senescence, telomerase, aging, DNA damage response,
cancer, chromosome stability, regenerative medicine, TERT, molecular aging
Introduction
Cellular aging is a complex biological process influenced by intrinsic genetic programs and
extrinsic environmental factors. One of the most studied molecular markers of aging is
telomere length. Telomeres are tandem repeats of the sequence TTAGGG located at the
termini of eukaryotic chromosomes. These structures, in conjunction with shelterin protein
complexes, protect chromosomes from degradation, end-to-end fusion, and DNA damage
responses. However, due to the end-replication problem inherent in DNA polymerase
activity, telomeres shorten with each cell division. Once they reach a critical length, cells
enter a state of replicative senescence or programmed death, which is considered a natural
barrier against malignant transformation.
The balance between telomere shortening and telomerase activity, an RNA-dependent DNA
polymerase that adds telomeric repeats to the 3’ end of chromosomes, is crucial for cellular
longevity. While most somatic cells have low or absent telomerase expression, stem cells
and cancer cells often upregulate this enzyme to maintain proliferative capacity. Thus,
understanding the biology of telomeres and their regulation has far-reaching implications in
both aging research and regenerative medicine.
Methods
This narrative review is based on a comprehensive analysis of peer-reviewed literature from
databases including PubMed, ScienceDirect, and Web of Science. The selection criteria
prioritized high-impact journals and recent advances in telomere biology, telomerase
function, and related disease processes. Both in vitro and in vivo studies, as well as clinical
trials involving telomerase-targeted therapies, were considered to provide a multidisciplinary
perspective on the topic. Articles were analyzed thematically to synthesize current
understanding and identify gaps in knowledge.
Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Results
Telomere shortening occurs progressively in proliferative tissues such as skin, bone marrow,
and vascular endothelium. Studies demonstrate that individuals with shorter leukocyte
telomere lengths have higher risks of cardiovascular diseases, type 2 diabetes, and certain
cancers. Mechanistically, shortened telomeres activate DNA damage responses, notably the
p53 and p21 pathways, resulting in cell cycle arrest and pro-inflammatory senescence-
associated secretory phenotypes (SASP). These senescent cells accumulate in aging tissues,
contributing to systemic inflammation and functional decline.
In cancer biology, paradoxically, the activation of telomerase allows malignant cells to
bypass senescence and become immortalized. Approximately 85–90% of human tumors
show elevated telomerase activity, often via upregulation of the TERT gene. Conversely, in
premature aging syndromes such as dyskeratosis congenita and Werner syndrome, mutations
affecting telomerase or telomere-associated proteins lead to accelerated telomere loss and
early-onset aging symptoms.
Recent therapeutic developments include small molecules that activate telomerase (e.g., TA-
65), gene therapy approaches targeting TERT expression, and CRISPR-based editing of
telomere regulators. However, safety concerns persist due to the potential for promoting
oncogenesis. Furthermore, lifestyle factors such as chronic stress, smoking, and poor diet
have been linked to telomere shortening, while exercise and antioxidant-rich diets may slow
telomere attrition.
Discussion
The biological role of telomeres extends beyond chromosomal protection. Their dynamic
shortening is now viewed as a molecular clock that regulates the replicative lifespan of cells.
Telomere biology offers insight into a unifying mechanism for multiple age-associated
conditions, providing both diagnostic and therapeutic potential. Importantly, telomere length
is influenced by genetic, epigenetic, and environmental factors, making it a valuable
biomarker for personalized medicine.
Nevertheless, therapeutic manipulation of telomere length must be approached cautiously.
While telomerase activation may confer benefits in degenerative diseases and tissue
regeneration, it also raises the risk of uncontrolled cell proliferation. Thus, dual strategies
that selectively preserve telomeres in non-malignant cells while suppressing telomerase in
cancerous tissues are currently under investigation.
Future research should focus on longitudinal human studies to determine the causative
versus correlative roles of telomere length in aging. Moreover, the integration of telomere
biology with other hallmarks of aging—such as mitochondrial dysfunction, epigenetic
alterations, and stem cell exhaustion—will provide a more comprehensive understanding of
age-related pathology.
Conclusion
Telomeres represent a molecular bridge between cellular biology and clinical aging. Their
shortening is a natural consequence of cellular replication but also a driver of age-associated
dysfunction and disease. Advances in telomere biology have opened new horizons for
diagnostic, prognostic, and therapeutic strategies in geriatric medicine, oncology, and
Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
regenerative therapies. However, the dual nature of telomerase—as both a potential
rejuvenating factor and an oncogenic enabler—necessitates precision in therapeutic targeting.
Interventions must be tailored to enhance healthy lifespan without compromising genomic
stability. As the field matures, telomeres may become central to interventions aimed not
only at prolonging life, but at improving its quality in aging populations.
References
1.
Blackburn, E. H., Greider, C. W., & Szostak, J. W. (2006). Telomeres and telomerase:
The path from maize, Tetrahymena and yeast to human cancer and aging.
Nature Medicine
,
12(10), 1133–1138.
2.
Shay, J. W., & Wright, W. E. (2019). Telomeres and telomerase: Three decades of
progress.
Nature Reviews Genetics
, 20(5), 299–309.
3.
López-Otín, C., et al. (2013). The hallmarks of aging.
Cell
, 153(6), 1194–1217.
4.
Boymirzayeva, S. (2025). DIDACTIC FORMS AND METHODS OF
PEDAGOGICAL SUPPORT AND TARGETED DEVELOPMENT OF CHILDREN IN
THE PROCESS OF PRESCHOOL EDUCATION.
Journal of Multidisciplinary Sciences
and Innovations
,
1
(1), 557-562.
5.
Sobirjonovich, S. I. (2023). Systemic Organization of Professional Competence,
Creativity and Innovative Activity of A Future Kindergartener.
Journal of Pedagogical
Inventions and Practices
,
19
, 108-112.
6.
Abdurashidov, A., & Turdaliyeva, N. (2023). DEVELOPMENT OF MANUAL
WORK IN PRE-SCHOOL EDUCATION.
Science and innovation
,
2
(B2), 282-286.
7.
Мухамедова, М. Г., Куртиева, Ш. А., & Назарова, Ж. А. (2020). СИНДРОМ
ФУНКЦИОНАЛЬНОЙ КАРДИОПАТИИ У СОВРЕМЕННЫХ ПОДРОСТКОВ. In
П84
Профилактическая медицина-2020: сборник научных трудов Все-российской научно-
практической конференции с международным участи-ем. 18–19 ноября 2020 года/под
ред. АВ Мельцера, ИШ Якубовой. Ч. 2.—СПб.: Изд-во СЗГМУ им. ИИ Мечникова,
2020.—304 с.
(p. 105).
8.
qizi Turdaliyeva, N. A. (2024). MAKTABGACHA YOSHDAGI BOLALAR IJODIY
QOBILIYATLARNI RIVOJLANTIRISHNING NAZARIY ASOSLARI.
GOLDEN
BRAIN
,
2
(7), 48-52.
9.
Юллиев, Н. Ж. (2022). Определение физической подготовленности спасателей в
условиях среднегорья. In
ТРУДЫ ХIII ЕВРАЗИЙСКОГО НАУЧНОГО ФОРУМА
(pp.
259-262).
10.
Turdaliyeva, N. (2025). DIFFERENT TYPES OF MANUAL LABOR FOR
CHILDREN AND THEIR IMPACT ON CREATIVE DEVELOPMENT.
Journal of
Multidisciplinary Sciences and Innovations
,
1
(1), 563-568.
11.
Файзуллаев, Т., & Хужамбердиева, Ш. (2020). ЭРКИН ВОҲИДОВ ИЖОДИНИ
УМУМИЙ ЎРТА ТАЪЛИМ МАКТАБЛАРИДА ЎРГАНИШДА ЁШЛАРНИ
ВАТАПАРВАРЛИК РУҲИДА ТАРБИЯЛАШНИНГ АҲАМИЯТИ.
Scientific Bulletin of
Namangan State University
,
2
(4), 543-546.
12.
Turdaliyeva, N., & Mamadjonova, D. (2024). MAKTABGACHA TA’LIM
TASHKILOTLARIDA BOLALARGA TA’LIM-TARBIYA BERISHDA IJODIY
O’YINLARDAN FOYDALANISH.
Nordic_Press
,
5
(0005).
13.
Mukhamedova, M., & Arnopolskaya, D. (2013). The Nitric Oxide System in Patients
with Chronic Heart Failure.
International Journal of Biomedicine
,
3
(3), 180-183.
Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
14.
Юллиев, Н. Ж., Сафарова, Д. Д., Мусаева, У. А., & Нурбаев, Б. Ш. (2015).
Особенности физической подготовки спасателей МЧС с учетом условий
среднегорья.
Наука и спорт: современные тенденции
,
8
(3), 47-53.
15.
Khujamberdieva, S. (2023). SPECIFIC TASKS OF INTRODUCING CHILDREN
TO LITERARY WORKS.
Collection of scientific papers «SCIENTIA»
, (May 5, 2023;
Sydney, Australia), 145-147.
16.
Armanios, M., & Blackburn, E. H. (2012). The telomere syndromes.
Nature Reviews
Genetics
, 13(10), 693–704.
